Methyl 4-chloro-7-methoxyquinoline-6-carboxylate

It’s a versatile building block in organic synthesis for creating quinoline-based compounds with diverse biological activities. Methyl 4-chloro-7-methoxyquinoline-6-carboxylate is a key pharmaceutical intermediate used to build complex drug molecules, especially anti-cancer drugs (like Lenvatinib, a tyrosine kinase inhibitor) and potential antimalarials, by acting as a building block for inhibiting tumor growth pathways (like VEGF) or targeting malaria parasites.